Sanofi has licensed gusacitinib, an oral JAK/SYK dual inhibitor from the “AI-native” drug development company Formation Bio, marking the pharma’s...
Latest
REDWOOD CITY, Calif., Jan. 30, 2024 — Zilliz Inc., a leader in vector database technology, proudly unveils the latest evolution of...
Forget everything you were taught in primary school. Raindrops are not tear-shaped. At least, not when they are falling through...
